Nathan Grubaugh, PhD < Yale School of Public Health
Par un écrivain mystérieux
Last updated 15 juillet 2024
Nathan Grubaugh joined the faculty at Yale School of Public Health in 2018. Before going to graduate school, he spent ~7 years working in the biotech industry
Nathan Grubaugh joined the faculty at Yale School of Public Health in 2018. Before going to graduate school, he spent ~7 years working in the biotech industry developing early phase vaccine candidates. He earned his MS in biotechnology from Johns Hopkins University (2011) while conducting research at the NIH and the US Army Research Institute of Infectious Diseases (focus on mosquito-borne virus surveillance). Dr. Grubaugh earned his PhD in microbiology from Colorado State University in 2016 (focus on West Nile virus evolution), and went on to be a postdoctoral fellow at The Scripps Research Institute to study the 2015-2017 Zika virus epidemic. Now at Yale, the Grubaugh Lab uses genomics and phylogenetics to uncover the epidemiological, ecological, and evolutionary determinants of virus outbreaks. They primarily focus on mosquito- and tick-borne viruses, like dengue, West Nile, and Powassan, that are increasingly spreading into new areas and have high outbreak potential. The Grubaugh Lab is diverse and multidisciplinary, including expertise in molecular biology, phylogenetics, statistics, and mathematical modeling. His lab was critical during the COVID-19 response, from designing and evaluating diagnostics (such as SalivaDirect) to establishing the Yale SARS-CoV-2 Genomic Surveillance Initiative to track emerging variants. Expanding on this work, the lab is an academic partner for the Pathogen Genomics Centers of Excellence to foster and improve innovation and technical capacity in pathogen genomics, molecular epidemiology, and bioinformatics to better prevent, control, and respond to microbial threats of public health importance. Read more about their team and work at grubaughlab.com.
Nathan Grubaugh joined the faculty at Yale School of Public Health in 2018. Before going to graduate school, he spent ~7 years working in the biotech industry developing early phase vaccine candidates. He earned his MS in biotechnology from Johns Hopkins University (2011) while conducting research at the NIH and the US Army Research Institute of Infectious Diseases (focus on mosquito-borne virus surveillance). Dr. Grubaugh earned his PhD in microbiology from Colorado State University in 2016 (focus on West Nile virus evolution), and went on to be a postdoctoral fellow at The Scripps Research Institute to study the 2015-2017 Zika virus epidemic. Now at Yale, the Grubaugh Lab uses genomics and phylogenetics to uncover the epidemiological, ecological, and evolutionary determinants of virus outbreaks. They primarily focus on mosquito- and tick-borne viruses, like dengue, West Nile, and Powassan, that are increasingly spreading into new areas and have high outbreak potential. The Grubaugh Lab is diverse and multidisciplinary, including expertise in molecular biology, phylogenetics, statistics, and mathematical modeling. His lab was critical during the COVID-19 response, from designing and evaluating diagnostics (such as SalivaDirect) to establishing the Yale SARS-CoV-2 Genomic Surveillance Initiative to track emerging variants. Expanding on this work, the lab is an academic partner for the Pathogen Genomics Centers of Excellence to foster and improve innovation and technical capacity in pathogen genomics, molecular epidemiology, and bioinformatics to better prevent, control, and respond to microbial threats of public health importance. Read more about their team and work at grubaughlab.com.
APHA Statements
New Innovator Award Recipients
Barry Scholarship
Yale Institute for Global Health on LinkedIn: The Second Annual Vector-borne and Zoonotic Diseases Symposium will be…
Global Health at Yale
ASTMH - ACAV (Arbovirology)
Discovery of hidden outbreak hints that Zika virus can spread silently
Instructors – SPSAS Epidemic Preparedness
Statement from Yale Faculty on Hydroxychloroquine and its Use in COVID-19, by Gregg Gonsalves
Canterbury Institute
Nathan GRUBAUGH, Assistant Professor, Ph.D., M.S., Yale University, CT, YU, Department of Epidemiology of Microbial Diseases
ASPPH COVID-19 Storytelling Project
Instructors – SPSAS Epidemic Preparedness
Recommandé pour vous
- Nathan Ledbetter Department of East Asian Studies14 Jul 2023
- Nathan Click - Ballotpedia14 Jul 2023
- Nathan Black Tippie College of Business14 Jul 2023
- Nathan Blanchet Results for Development14 Jul 2023
- Nathan Dollar named Director of Carolina Demography14 Jul 2023
- Nathan Beckord - Fundingstack14 Jul 2023
- Nathan Reiff14 Jul 2023
- Nathan Gianneschi: Department of Chemistry - Northwestern University14 Jul 2023
- Nathan for You Rotten Tomatoes14 Jul 2023
- Scott Nathan14 Jul 2023
Tu pourrais aussi aimer
- External PCI-e SSD (7+17 pins) enclosure or case for Apple Macbook14 Jul 2023
- Batterie AGM EFFEKTA 12 V - 75 Ah14 Jul 2023
- Coque Étui Lenovo Tab M10 FHD Plus (10.3) TB-X606F TB-X606X Housse de Protection Folio avec Support - SZHD - Cdiscount Informatique14 Jul 2023
- Articles de puériculture, jeu d'éveil pour bébé, tétines14 Jul 2023
- Wireless Mic – Pivo14 Jul 2023
- ZLL SG108 RC Drone avec Caméra Réglable 4K Une Batterie Noir14 Jul 2023
- iPad 6 (2018) Touch Screen Replacement w/ Home Button - White14 Jul 2023
- Bouton DE Couture Blanc Nacré En Taille 30 mm, 3 Cm, Pour Vetements14 Jul 2023
- Où trouver une lampe frontale à LED rechargeable à Caen 14 ? - Promat Sécurité14 Jul 2023
- DeepCool LT720 AIO CPU Cooler Review14 Jul 2023